Eupraxia Pharmaceuticals Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Eupraxia Pharmaceuticals Inc. (EPRX) is 157.76M

According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 157.76M. This represents a change of -55.45% compared to the average of 354.10M of the last 4 quarters.

Eupraxia Pharmaceuticals Inc. (EPRX) Historical Enterprise Value (quarterly & annually)

How has EPRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Eupraxia Pharmaceuticals Inc. over the last ten years is 114.46M. The current 157.76M Enterprise Value has changed 13.68% with respect to the historical average. Over the past ten years (40 quarters), EPRX's Enterprise Value was at its highest in in the March 2026 quarter at 512.86M. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.

Eupraxia Pharmaceuticals Inc. (EPRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eupraxia Pharmaceuticals Inc. (EPRX) Average Enterprise Value

How has EPRX Enterprise Value performed in the past?

The current Enterprise Value of Eupraxia Pharmaceuticals Inc. (EPRX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eupraxia Pharmaceuticals Inc. (EPRX) Enterprise Value vs. Peers

How is EPRX’s Enterprise Value compared to its peers?

Eupraxia Pharmaceuticals Inc.’s Enterprise Value is greater than MediWound Ltd. (147.82M), greater than Nautilus Biotechnolgy, Inc. (146.81M), greater than Neonc Technologies Holdings, Inc. (90.97M), less than Orchestra BioMed Holdings, Inc. (232.81M), greater than Aardvark Therapeutics, Inc. Common Stock (54.32M), less than SELLAS Life Sciences Group, Inc. (1.77B), less than Inventiva S.A. (507.06M), greater than Cartesian Therapeutics, Inc. (111.22M), less than Genfit S.A. (729.68M), less than Protara Therapeutics, Inc. (202.46M),

Build a custom stock screener for Eupraxia Pharmaceuticals Inc. (EPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eupraxia Pharmaceuticals Inc. (EPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.